Attain StabilityTM Quad Clinical Study

Completed

• Conditions: desynchronization; heart failure; 10019280

• Registration Number: NL-OMON45275
• Lead Sponsor: Medtronic BV

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

- Patient meets CRT implant criteria as determined by local regulatory and/or hospital policy.
- Patient has signed and dated the study-specific Consent Form

Exclusion Criteria

- Patient has had a previous unsuccessful LV lead implant attempt.
- Patient has an existing epicardial LV lead

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary Safety Objective: Lead complication-free rate at 6 months<br /><br>Primary Efficacy Objectives: Lead pacing capture thresholds at 6 months</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The secondary objectives are descriptive in nature and are intended to provide<br /><br>additional information about the Attain Stability Quad Model 4798 LV lead.</p><br>